Saxenda

Description:

Saxenda is indicated as an adjunct to a low-calorie diet and increased physical activity for long-term use in order to correct body weight in adult patients with BMI: ≥30 kg / m2 (obesity) or ≥27 kg / m2 to <30 kg / m2 (excessive body weight) in the presence of at least one concomitant disease associated with overweight, such as prediabetes, type 2 diabetes mellitus, arterial hypertension, dyslipidemia or obstructive sleep apnea syndrome, and Saxenda can be used as an adjunct to a healthy diet and increased physical activity to correct body weight in adolescents aged 12 years and older with a body weight of over 60 kg and obesity (BMI corresponding to ≥30 kg / m2 (obesity) for adults according to international thresholds).